|
|
Line 1: |
Line 1: |
| | | |
| ==Refined solution structure and dynamics of First Catalytic Cysteine Half-domain from mouse E1 enzyme== | | ==Refined solution structure and dynamics of First Catalytic Cysteine Half-domain from mouse E1 enzyme== |
- | <StructureSection load='2lzj' size='340' side='right'caption='[[2lzj]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='2lzj' size='340' side='right'caption='[[2lzj]]' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[2lzj]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LZJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LZJ FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[2lzj]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2LZJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2LZJ FirstGlance]. <br> |
- | </td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[1z7l|1z7l]], [[3cmm|3cmm]]</div></td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2lzj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2lzj OCA], [https://pdbe.org/2lzj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2lzj RCSB], [https://www.ebi.ac.uk/pdbsum/2lzj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2lzj ProSAT]</span></td></tr> |
- | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Uba1, Sbx, Ube1, Ube1ax, Ube1x ([https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice])</td></tr>
| + | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2lzj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2lzj OCA], [https://pdbe.org/2lzj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2lzj RCSB], [https://www.ebi.ac.uk/pdbsum/2lzj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2lzj ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| == Function == | | == Function == |
- | [[https://www.uniprot.org/uniprot/UBA1_MOUSE UBA1_MOUSE]] Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding an ubiquitin-E1 thioester and free AMP.
| + | [https://www.uniprot.org/uniprot/UBA1_MOUSE UBA1_MOUSE] Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding an ubiquitin-E1 thioester and free AMP. |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 27: |
Line 25: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Lk3 transgenic mice]] | + | [[Category: Mus musculus]] |
- | [[Category: Bochtler, M]] | + | [[Category: Bochtler M]] |
- | [[Category: Ejchart, A]] | + | [[Category: Ejchart A]] |
- | [[Category: Filipek, R]] | + | [[Category: Filipek R]] |
- | [[Category: Jaremko, L]] | + | [[Category: Jaremko L]] |
- | [[Category: Jaremko, M]] | + | [[Category: Jaremko M]] |
- | [[Category: Nowakowski, M]] | + | [[Category: Nowakowski M]] |
- | [[Category: Szczepanowski, R H]] | + | [[Category: Szczepanowski RH]] |
- | [[Category: Wojciechowski, M]] | + | [[Category: Wojciechowski M]] |
- | [[Category: Beta-barrel architecture]]
| + | |
- | [[Category: Catalytic half-domain]]
| + | |
- | [[Category: Flexible thermini]]
| + | |
- | [[Category: Ligase]]
| + | |
- | [[Category: Mouse e1 enzyme]]
| + | |
- | [[Category: Protein degradation]]
| + | |
- | [[Category: Ubiquitinylation]]
| + | |
| Structural highlights
Function
UBA1_MOUSE Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding an ubiquitin-E1 thioester and free AMP.
Publication Abstract from PubMed
We report a high resolution NMR structure and 15N relaxation studies of the first catalytic cysteine half-domain (FCCH) of the mouse ubiquitin-activating enzyme E1, together with interaction studies of FCCH and the other catalytic E1 subdomain - SCCH (second catalytic cysteine half-domain). In solution, mouse FCCH forms a well-defined six-stranded antiparallel beta-barrel structure, a common fold for many proteins with a variety of cellular functions. 15N relaxation data reveal FCCH complex backbone dynamics and indicate which residues experience slow intramolecular motions. Some of these residues make contacts with the polar face of ubiquitin in the co-crystal structure of yeast E1 and ubiquitin. However, the titration of FCCH with ubiquitin does not show any visible chemical shift changes in the 2D 1H/15N HSQC spectra of the FCCH. The 2D 1H/15N HSQC experiments performed both for each catalytic half-domain individually and for their equimolar mixture in the milimolar concentration range display no detectable chemical shift perturbation, suggesting a lack of interaction between the two subdomains unless they are covalently linked via the adenylation domain.
NMR structural studies of the first catalytic half-domain of ubiquitin activating enzyme.,Jaremko M, Jaremko L, Nowakowski M, Wojciechowski M, Szczepanowski RH, Panecka R, Zhukov I, Bochtler M, Ejchart A J Struct Biol. 2013 Nov 6. pii: S1047-8477(13)00299-2. doi:, 10.1016/j.jsb.2013.10.020. PMID:24211821[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Jaremko M, Jaremko L, Nowakowski M, Wojciechowski M, Szczepanowski RH, Panecka R, Zhukov I, Bochtler M, Ejchart A. NMR structural studies of the first catalytic half-domain of ubiquitin activating enzyme. J Struct Biol. 2013 Nov 6. pii: S1047-8477(13)00299-2. doi:, 10.1016/j.jsb.2013.10.020. PMID:24211821 doi:http://dx.doi.org/10.1016/j.jsb.2013.10.020
|